Department of Surgery, School of Medicine and Dentistry, North Queensland Centre for Cancer Research, James Cook University, Townsville, QLD, Australia.
World J Surg. 2010 May;34(5):1091-101. doi: 10.1007/s00268-010-0443-2.
Obstruction (OBSTR) and perforation (PERF) in colorectal cancer impact adversely upon outcomes, and cancer-related survival may also be affected. However, data are sparse, particularly on disease-free survival (DFS) where the cancer is both obstructed and perforated (OBS-PERF).
Data were extracted from a prospectively collected database of 1876 colorectal cancer patients managed and followed up at the Royal Brisbane Hospital from 1984 to 2004. The patients who had curative surgery (n = 1426) were classified as OBSTR (n = 153), PERF (n = 53), OBS-PERF (n = 19), and uncomplicated (UNCOM; n = 1201). Kaplan-Meier survival and Cox proportional hazard analyses were performed.
Postoperative mortality within 30 days of surgery was 1.5% (n = 22) and the overall complication rate was 40.8% (n = 582). However, only 7.2% (n = 102) required reoperations. The median survival time was 71 (IQR = 64.9-77.1) months and the median follow-up for DFS was 37.5 (IQR 14-68) months. The overall recurrence rate was 32.7% (n = 466), the local recurrence rate was 9.4% (n = 135), and local and distant recurrences occurred in the same patient in 4.7% (n = 67). Male gender, OBSTR, PERF, OBS-PERF, emergency operation, major medical and surgical complications, reoperation, TNM staging, tumor grading, and tumor venous invasion adversely affected DFS (p < 0.05). Multivariate analysis showed that OBS-PERF (p = 0.008), major medical complications (p = 0.011), reoperation (p = 0.018), TNM staging (p < 0.001), grading (p = 0.018), and venous invasion (p = 0.002) were independently associated with a poorer DFS.
OBS-PERF colorectal cancer is associated with a poorer DFS, which may be worse than either OBSTR or PERF alone.
结直肠癌的梗阻(OBSTR)和穿孔(PERF)会对预后产生不利影响,癌症相关的生存率也可能受到影响。然而,相关数据较为匮乏,尤其是在结直肠癌同时梗阻和穿孔(OBS-PERF)的情况下,关于无病生存率(DFS)的数据尤其缺乏。
从 1984 年至 2004 年在皇家布里斯班医院接受治疗和随访的 1876 例结直肠癌患者的前瞻性数据库中提取数据。接受根治性手术的患者(n=1426)分为 OBSTR(n=153)、PERF(n=53)、OBS-PERF(n=19)和无并发症(UNCOM;n=1201)。进行 Kaplan-Meier 生存分析和 Cox 比例风险分析。
术后 30 天内死亡率为 1.5%(n=22),总并发症发生率为 40.8%(n=582)。但仅有 7.2%(n=102)需要再次手术。中位生存时间为 71 个月(IQR=64.9-77.1),DFS 的中位随访时间为 37.5 个月(IQR=14-68)。总复发率为 32.7%(n=466),局部复发率为 9.4%(n=135),4.7%(n=67)的患者同时出现局部和远处复发。男性、OBSTR、PERF、OBS-PERF、急诊手术、重大医疗和手术并发症、再次手术、TNM 分期、肿瘤分级和肿瘤静脉侵犯均对 DFS 产生不利影响(p<0.05)。多因素分析显示,OBS-PERF(p=0.008)、重大医疗并发症(p=0.011)、再次手术(p=0.018)、TNM 分期(p<0.001)、分级(p=0.018)和静脉侵犯(p=0.002)与较差的 DFS 相关。
OBS-PERF 结直肠癌与较差的 DFS 相关,其预后可能比单独的 OBSTR 或 PERF 更差。